As the immediate pandemic threat fades, the prospect and realities of new regulations become top of mind for many operators. This session looks at regulatory trends, priorities and interests for state regulators, and opportunities for industry/regulator collaboration on model guidance. This session also gets into readiness planning, risk assessment/risk management, and other topics to help industry leaders prepare for regulatory changes.
- Rhonda DeMeno, Director of Clinical Risk, Willis Towers Watson
- Alfred Johnson, President, National Association for Regulatory Administration (NARA)
Moderator: John M. Schulte, Vice President, Quality Improvement, Argentum